A wide range of BioBall® products to meet diverse customer needs

As world leader in the field of industrial microbiology control, bioMérieux is proud to celebrate the 10th anniversary of BioBall®, an innovative technology for quantitative microbiology Quality Control for the biopharmaceutical and cosmetic industries.

The patented BioBall technology uses a small, water-soluble ball containing a precise number of viable micro-organisms derived from strains sourced from internationally-recognized culture collections. Over the past 10 years, Bioball technology has been used in quality assurance to verify the performance of control methods and allow certification of the quality of culture media faster and with unprecedented accuracy than other methods. With the acquisition of the Australian company BTF in 2007, bioMérieux enlarged its product portfolio and brought solutions integrating BTF´s innovative technology, such as BioBall, to a wide customer base.

"We have a long lasting commitment in delivering to our customers confidence in our quantitative microbiology solutions," declared Nicolas Cartier, Corporate Vice-President, Industrial Microbiology Unit of bioMérieux. "With Bioball, Quantitative Microbiological Quality Control has been brought to a new level.

" With more than 25 strains currently available, the BioBall menu has experienced constant development over the last decade. Since 2010, customers wishing to perform quality control with their own plant isolates or wild strains have been able to do so thanks to the BioBall Custom Services (Plant Isolate) option. In addition, the BioBall Mixed Kits in packs containing 10 of the most relevant pharmacopoeia strains required for quantitative microbiology brought additional flexibility and convenience to laboratories performing small numbers of samples per day. Today, BioBall is used routinely by the top 20 biopharmaceutical industries worldwide.

The anniversary of Bioball marks 10 years of expertise in providing precise quantitative reference samples for use in analytical laboratories worldwide. bioMérieux will continue to foster innovation and development over the next decades to bring high quality solutions to its customers throughout the world. With the acquisition of the Australian company BTF in 2007, bioMérieux enlarged its product portfolio and brought solutions integrating BTF´s innovative technology, such as BioBall, to a wide customer base.

"We have a long lasting commitment in delivering to our customers confidence in our quantitative microbiology solutions," declared Nicolas Cartier, Corporate Vice-President, Industrial Microbiology Unit of bioMérieux. "With Bioball, Quantitative Microbiological Quality Control has been brought to a new level.

" With more than 25 strains currently available, the BioBall menu has experienced constant development over the last decade. Since 2010, customers wishing to perform quality control with their own plant isolates or wild strains have been able to do so thanks to the BioBall Custom Services (Plant Isolate) option. In addition, the BioBall Mixed Kits in packs containing 10 of the most relevant pharmacopoeia strains required for quantitative microbiology brought additional flexibility and convenience to laboratories performing small numbers of samples per day. Today, BioBall is used routinely by the top 20 biopharmaceutical industries worldwide.

The anniversary of Bioball marks 10 years of expertise in providing precise quantitative reference samples for use in analytical laboratories worldwide. bioMérieux will continue to foster innovation and development over the next decades to bring high quality solutions to its customers throughout the world.